Literature DB >> 30755717

PD-1 is expressed by and regulates human group 3 innate lymphoid cells in human decidua.

Paola Vacca1, Silvia Pesce2, Lorenzo Moretta3, Emanuela Marcenaro4, Marco Greppi2, Ezio Fulcheri5,6, Enrico Munari7,8, Daniel Olive9, Maria Cristina Mingari2,10, Alessandro Moretta2.   

Abstract

Group 3 innate lymphoid cells (ILC3) have been detected in both murine and human decidual tissues where they are thought to play a relevant role in the induction and maintenance of pregnancy. However, limited information exists on the molecular mechanisms that regulate these cells, including immune checkpoints. Here, we show that ILC3 express the inhibitory checkpoints programmed cell death (PD-1) and T cell immunoglobulin and mucin domain containing protein 3 (TIM-3) during the first trimester of pregnancy and that these receptors could regulate production of cytokines, including IL-22, IL-8, and TNF-α, induced by IL-23. We also show that the intermediate extravillous trophoblast (iEVT) expresses high levels of the PD-1-ligand PD-L1, suggesting that PD-1/PD-L1 interaction may regulate ILC3 function at the feto-maternal interface. Our present data provide the first evidence that human decidual ILC3 express a functional PD-1. It is possible that an altered expression or function of PD-1 may break the immune-tolerance resulting in pregnancy failure.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30755717     DOI: 10.1038/s41385-019-0141-9

Source DB:  PubMed          Journal:  Mucosal Immunol        ISSN: 1933-0219            Impact factor:   7.313


  25 in total

Review 1.  Emerging concepts in PD-1 checkpoint biology.

Authors:  Kristen E Pauken; James A Torchia; Apoorvi Chaudhri; Arlene H Sharpe; Gordon J Freeman
Journal:  Semin Immunol       Date:  2021-05-15       Impact factor: 11.130

Review 2.  Deciphering the Roles of Innate Lymphoid Cells in Cancer.

Authors:  Melanie Bruchard; Francois Ghiringhelli
Journal:  Front Immunol       Date:  2019-04-03       Impact factor: 7.561

Review 3.  PD/1-PD-Ls Checkpoint: Insight on the Potential Role of NK Cells.

Authors:  Silvia Pesce; Marco Greppi; Francesco Grossi; Genny Del Zotto; Lorenzo Moretta; Simona Sivori; Carlo Genova; Emanuela Marcenaro
Journal:  Front Immunol       Date:  2019-06-04       Impact factor: 7.561

Review 4.  Innate Lymphoid Cells: Expression of PD-1 and Other Checkpoints in Normal and Pathological Conditions.

Authors:  Francesca Romana Mariotti; Linda Quatrini; Enrico Munari; Paola Vacca; Lorenzo Moretta
Journal:  Front Immunol       Date:  2019-04-26       Impact factor: 7.561

Review 5.  Uterine natural killer cells: Time for a re-appraisal?

Authors:  Judith N Bulmer; Gendie E Lash
Journal:  F1000Res       Date:  2019-07-02

Review 6.  Perinatal Mesenchymal Stromal Cells and Their Possible Contribution to Fetal-Maternal Tolerance.

Authors:  Marta Magatti; Francesca Romana Stefani; Andrea Papait; Anna Cargnoni; Alice Masserdotti; Antonietta Rosa Silini; Ornella Parolini
Journal:  Cells       Date:  2019-11-07       Impact factor: 6.600

Review 7.  Mechanisms of hyperprogressive disease after immune checkpoint inhibitor therapy: what we (don't) know.

Authors:  Simone Camelliti; Valentino Le Noci; Francesca Bianchi; Claudia Moscheni; Francesca Arnaboldi; Nicoletta Gagliano; Andrea Balsari; Marina Chiara Garassino; Elda Tagliabue; Lucia Sfondrini; Michele Sommariva
Journal:  J Exp Clin Cancer Res       Date:  2020-11-09

Review 8.  Immunoregulatory Sensory Circuits in Group 3 Innate Lymphoid Cell (ILC3) Function and Tissue Homeostasis.

Authors:  Rita G Domingues; Matthew R Hepworth
Journal:  Front Immunol       Date:  2020-02-06       Impact factor: 7.561

Review 9.  The Role of B7 Family Molecules in Maternal-Fetal Immunity.

Authors:  Yongbo Zhao; Qingliang Zheng; Liping Jin
Journal:  Front Immunol       Date:  2020-03-24       Impact factor: 7.561

Review 10.  Helper Innate Lymphoid Cells in Human Tumors: A Double-Edged Sword?

Authors:  Nicola Tumino; Paola Vacca; Linda Quatrini; Enrico Munari; Francesca Moretta; Andrea Pelosi; Francesca Romana Mariotti; Lorenzo Moretta
Journal:  Front Immunol       Date:  2020-01-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.